DiagnaMed Holdings Corp. announced the pilot launch of CERVAI?, a consumer brain health and wellness AI solution that aims to ?raise a red flag? for potential brain health issues by estimating brain age and providing a brain health score.

Based on research and development at Drexel University and the University of Miami, CERVAI? combines a Brain Age? Estimation and Brain Health Assessment tool.

CERVAI? can assess if a brain is aging more quickly or more slowly than is typical for healthy individuals. Brain age is estimated by collecting neural activity data of the brain with a low-cost and easy-to-use electroencephalogram (?EEG?) headset and calculating the data with a proprietary machine-learning model.

In addition, CERVAI? can assess if a person has a healthy brain or is in the early stage of cognitive decline. Brain health is scored by taking a clinically validated assessment for brain resilience, vulnerability and performance functions.

Individuals can seek out personalized diagnostics and interventions, such as medication or lifestyle changes, that may help to decrease the development or progression of cognitive decline. The CERVAI? Brain Health pilot program is open to a select 25 consumer wellness clinics in the U.S. and Canada over the next three months.

Ideal clinics for the pilot program must focus on health and wellness, sports and physical therapy, mental health, chiropractic care, or clinical research for neurological and cognitive disorders.